PDGFRB and angiosarcoma: Additionally, PDGFRβ expression can be a useful biomarker for the prediction of a cancer prognosis7, for example, a significant positive correlation between PDGFRβ expression and short overall survival (OS) in patients with angiosarcoma has been reported8.